Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 5,534 | 3,369 | 4,333 | 4,761 | 4,610 |
| Gross Profit | 5,534 | 3,369 | 4,333 | 4,761 | 4,610 |
| Operating Expenses | 16,199 | 16,559 | 18,238 | 16,155 | 15,356 |
| Operating Income | -10,665 | -13,190 | -13,905 | -11,395 | -10,746 |
| Other Income | 248 | 325 | 100 | 777 | 831 |
| Pre-tax Income | -10,417 | -12,865 | -13,805 | -10,618 | -9,915 |
| Income Tax | 1 | N/A | 20 | N/A | -1 |
| Net Income Continuous | -10,418 | -12,865 | -13,826 | -10,618 | -9,914 |
| Net Income | $-10,418 | $-12,865 | $-13,826 | $-10,618 | $-9,914 |
| EPS Basic Total Ops | -0.09 | -0.12 | -0.14 | -0.11 | -0.11 |
| EPS Basic Continuous Ops | -0.10 | -0.12 | -0.13 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.09 | -0.12 | -0.14 | -0.11 | -0.11 |
| EPS Diluted Continuous Ops | -0.10 | -0.12 | -0.13 | -0.10 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.12 | -0.14 | -0.11 | -0.10 |
| EBITDA(a) | $-9,973 | $-12,360 | $-13,083 | $-10,680 | $-10,056 |